The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrimary Health Regulatory News (PHP)

Share Price Information for Primary Health (PHP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 97.00
Bid: 96.90
Ask: 97.05
Change: 0.50 (0.52%)
Spread: 0.15 (0.155%)
Open: 96.85
High: 97.45
Low: 96.15
Prev. Close: 96.50
PHP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

13 May 2021 10:34

RNS Number : 5421Y
Primary Health Properties PLC
13 May 2021
 

Primary Health Properties PLC

Director's & PDMR dealings

On 12 May 2021, the remuneration committee of Primary Health Properties PLC (the "Company" or "PHP") made the following awards of nil-cost options under the Company's 2021 Long-term Incentive Plan ("LTIP") to a Director and Persons Discharging Managerial Responsibilities ("PDMR's").

Director

Number of shares under option

Richard Howell

266,904

PDMR

Christopher Santer

150,467

David Bateman

143,461

 

The number of nil-cost options were calculated by reference to a price of £1.50, being the average of the middle market quotation for the Company's ordinary shares between Friday 7 May 2021 and Tuesday 11 May 2021.

The nil-cost options will normally vest on the third anniversary of grant, subject to the attainment of performance conditions. The remuneration committee has the discretion to adjust the awards downwards at vesting for malus reasons. Details of the operation of the LTIP are set out in the Company's 2020 Report and Accounts.

Details of the transactions referenced above are included below in accordance with the under Article 19 of the retained EU law version of the Market Abuse Regulation (Regulation 596/2014).

1

Details of Person Discharging Managerial Responsibility/person closely associated with them ("PCA")

(a)

Name

Richard Howell

 

2

Reason for the notification

(a)

Position/status

Chief Financial Officer

(b)

Initial notification/ amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

(a)

Name of Entity

 

Primary Health Properties PLC

(b)

Legal Entity Identifier

213800Y5CJHXOATK7X11

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted

(a)

Description of the financial instrument

Ordinary shares of 12.5p

ISIN: GB00BYRJ5J14

(b)

Nature of the transaction

Award of nil-cost options over the Company's ordinary shares

 

(c)

Aggregated information

Price(s) and volume(s)

Price(s)

Volume(s)

Nil cost

266,904

 

(d)

Aggregated volume price

Single transaction: N/A

 

(e)

Date of transaction

12 May 2021

 

(f)

Place of transaction

n/a

 

 

1

Details of Person Discharging Managerial Responsibility/person closely associated with them ("PCA")

(a)

Name

Chris Santer

 

2

Reason for the notification

(a)

Position/status

PDMR

(b)

Initial notification/ amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

(a)

Name of Entity

 

Primary Health Properties PLC

(b)

Legal Entity Identifier

213800Y5CJHXOATK7X11

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted

(a)

Description of the financial instrument

Ordinary shares of 12.5p

ISIN: GB00BYRJ5J14

(b)

Nature of the transaction

Award of nil-cost options over the Company's ordinary shares

 

(c)

Aggregated information

Price(s) and volume(s)

Price(s)

Volume(s)

Nil cost

150,467

 

(d)

Aggregated volume price

Single transaction: N/A

 

(e)

Date of transaction

12 May 2021

 

(f)

Place of transaction

N/A

 

 

1

Details of Person Discharging Managerial Responsibility/person closely associated with them ("PCA")

(a)

Name

David Bateman

 

2

Reason for the notification

(a)

Position/status

PDMR

(b)

Initial notification/ amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

(a)

Name of Entity

 

Primary Health Properties PLC

(b)

Legal Entity Identifier

213800Y5CJHXOATK7X11

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted

(a)

Description of the financial instrument

Ordinary shares of 12.5p

ISIN: GB00BYRJ5J14

(b)

Nature of the transaction

Award of nil-cost options over the Company's ordinary shares

 

(c)

Aggregated information

Price(s) and volume(s)

Price(s)

Volume(s)

Nil cost

143,461

 

(d)

Aggregated volume price

Single transaction: N/A

 

(e)

Date of transaction

12 May 2021

 

(f)

Place of transaction

n/a

 

 

More information on Primary Health Properties PLC can be found on www.phpgroup.co.uk

 

Further details:

Harry Hyman

Chief Executive Officer

Tel: +44 (0) 20 7451 7050

Steven Owen

Chairman

Tel: +44 (0) 20 7451 7050

Richard Howell

Chief Financial Officer

Tel: +44 (0) 20 7104 5599

David Rydell / Steph Watson (Buchanan Communications)

Tel: +44 (0) 20 7466 5066

 

Legal Entity Identifier: 213800Y5CJHXOATK7X11

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGCGDUDXBDGBX
Date   Source Headline
20th Jun 20237:00 amRNSNotice of Interim Results
19th Jun 20233:26 pmRNSDirector/PDMR Shareholding
19th Jun 20233:23 pmRNSDirector/PDMR Shareholding
14th Jun 20239:26 amRNSHolding(s) in Company
22nd May 20239:47 amRNSDirector/PDMR Shareholding
15th May 20239:18 amRNSDirector/PDMR Shareholding
26th Apr 20233:10 pmRNSDirector/PDMR Shareholding
21st Apr 20233:58 pmRNSDirector/PDMR Shareholding
19th Apr 20233:23 pmRNSAGM Statement
19th Apr 20237:00 amRNSQ1 2023 Trading Update
11th Apr 20232:46 pmRNSDirector/PDMR Shareholding
11th Apr 20232:44 pmRNSDirector/PDMR Shareholding
6th Apr 202311:14 amRNSDirector’s & PDMR dealings
31st Mar 20239:20 amRNSHolding(s) in Company
23rd Mar 20237:00 amRNSNotice of Interim Dividend
15th Mar 20233:44 pmRNSDirector/PDMR Shareholding
15th Mar 20233:41 pmRNSDirector/PDMR Shareholding
15th Mar 202310:29 amRNSDirector/PDMR Shareholding
15th Mar 20238:39 amRNSAnnual Financial Report
14th Mar 202312:28 pmRNSDirector/PDMR Shareholding
6th Mar 202311:23 amRNSHolding(s) in Company
1st Mar 20239:43 amRNSDirector/PDMR Shareholding
1st Mar 20238:59 amRNSCompany Secretary Change
28th Feb 20234:17 pmRNSDirector/PDMR Shareholding
27th Feb 20234:56 pmRNSDirector/PDMR Shareholding
22nd Feb 20237:00 amRNSPreliminary Results
16th Feb 202311:38 amRNSHolding(s) in Company
8th Feb 202310:07 amRNSHolding(s) in Company
1st Feb 20239:40 amRNSHolding(s) in Company
23rd Jan 20237:00 amRNSAcquisition
16th Jan 20237:00 amRNSNotice of Preliminary Results
5th Jan 20237:00 amRNSDividend Declaration
19th Dec 202212:02 pmRNSDirector/PDMR Shareholding
15th Dec 20229:56 amEQSProactive Research Analyst Manos Halicioglu looks at Primary Health Properties
12th Dec 20227:00 amRNSSuccession Planning
6th Dec 20223:10 pmRNSHolding(s) in Company
30th Nov 202211:55 amRNSDirector/PDMR Shareholding
25th Nov 20222:19 pmRNSHolding(s) in Company
10th Nov 202210:30 amRNSDirector/PDMR Shareholding
7th Nov 202211:07 amRNSAppointment of joint broker
21st Oct 202212:01 pmRNSDirector/PDMR Shareholding
21st Oct 202212:00 pmRNSDirector/PDMR Shareholding
21st Oct 202212:00 pmRNSDirector/PDMR Shareholding
20th Oct 20224:39 pmRNSHolding(s) in Company
13th Oct 20225:00 pmRNSConvertible Bond Adjustment
6th Oct 20227:00 amRNSDividend Declaration
27th Sep 20227:00 amRNSValue Creation Award Win
14th Sep 20225:36 pmRNSDirector/PDMR Shareholding
14th Sep 20225:33 pmRNSDirector/PDMR Shareholding
12th Sep 202212:06 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.